HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Linda Ohrmund Selected Research

4- (3- (4- butylpiperidin- 1- yl)propyl)- 7- fluoro- 4H- benzo(1,4)oxazin- 3- one

2/2010AC-260584, an orally bioavailable M(1) muscarinic receptor allosteric agonist, improves cognitive performance in an animal model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Linda Ohrmund Research Topics

Disease

2Crohn Disease (Crohn's Disease)
10/2015 - 06/2013
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
06/2013 - 08/2012
1Ulcerative Colitis
06/2013
1Hypersensitivity (Allergy)
08/2012
1Cognitive Dysfunction
02/2010
1Alzheimer Disease (Alzheimer's Disease)
02/2010
1Schizophrenia (Dementia Praecox)
02/2010

Drug/Important Bio-Agent (IBA)

3AntibodiesIBA
10/2015 - 08/2012
3Infliximab (Remicade)FDA Link
10/2015 - 08/2012
2Pharmaceutical PreparationsIBA
06/2013 - 08/2012
14- (3- (4- butylpiperidin- 1- yl)propyl)- 7- fluoro- 4H- benzo(1,4)oxazin- 3- oneIBA
02/2010